World Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.

Press releases published on May 4, 2026

May 4, 2026

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU

Indeterminate GlobeNewswire

May 4, 2026

JellyFit Claims Evaluated: The Truth About Jelly Lean Fit Weight Loss Drops' 8 Ingredients Stacked with Gelatin Trick Recipe Hack Exposed

Indeterminate GlobeNewswire

May 4, 2026

Harlingen Professional Dr. Stanley Sy Announces Scholarship for Medical Education

Indeterminate EIN Presswire

May 4, 2026

Azalee Group Shares Japan's Aging Lessons at STS Forum Japan-Thailand 2026

Indeterminate EIN Presswire

May 4, 2026

Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply

Indeterminate GlobeNewswire

May 4, 2026

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Indeterminate GlobeNewswire

May 4, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Teva to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire

May 4, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire

May 4, 2026

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire

May 4, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Indeterminate GlobeNewswire

May 4, 2026

Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

Indeterminate GlobeNewswire

May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire

May 4, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

Indeterminate GlobeNewswire

May 4, 2026

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Indeterminate GlobeNewswire

May 4, 2026

REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER

Indeterminate GlobeNewswire

May 4, 2026

AI Therapy 2026 Report Shows Holistic Shift; Therapy-Chats.com Goes Beyond AI Apps, According to BlockchainzTech

Indeterminate EIN Presswire